BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12631106)

  • 1. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease.
    Anders HJ; Vielhauer V; Schlöndorff D
    Kidney Int; 2003 Feb; 63(2):401-15. PubMed ID: 12631106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the chemokine network in renal inflammation.
    Eis V; Vielhauer V; Anders HJ
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):164-72. PubMed ID: 15247883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nephrotic Syndrome is an immunoinflammatory disorder.
    Camici M
    Med Hypotheses; 2007; 68(4):900-5. PubMed ID: 17184932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.
    Furuichi K; Kaneko S; Wada T
    Clin Exp Nephrol; 2009 Feb; 13(1):9-14. PubMed ID: 19085040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting chemokines in proteinuria-induced renal disease.
    Moreno JA; Moreno S; Rubio-Navarro A; Sastre C; Blanco-Colio LM; Gómez-Guerrero C; Ortiz A; Egido J
    Expert Opin Ther Targets; 2012 Aug; 16(8):833-45. PubMed ID: 22793382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
    Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
    Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
    Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemokines in progressive renal disease.
    Zoja C; Garcia PB; Remuzzi G
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1815-22. PubMed ID: 19273165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists.
    Anders HJ; Ninichuk V; Schlöndorff D
    Kidney Int; 2006 Jan; 69(1):29-32. PubMed ID: 16374420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection.
    Stasikowska O; Wagrowska-Danilewicz M
    Med Sci Monit; 2007 Feb; 13(2):RA31-6. PubMed ID: 17261994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
    Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
    J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney diseases and chemokines.
    Panzer U; Steinmetz OM; Stahl RA; Wolf G
    Curr Drug Targets; 2006 Jan; 7(1):65-80. PubMed ID: 16454700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chemokines and chemokine receptors in progressive renal diseases.
    Segerer S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S15-8. PubMed ID: 12612944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V; Anders HJ; Schlöndorff D
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and renal inflammation.
    Panzer U; Stahl RA
    Nephrologie; 1999; 20(6):335-41. PubMed ID: 10592936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Chemokine Receptors in Renal Fibrosis.
    Wu F; Sun C; Lu J
    Rev Physiol Biochem Pharmacol; 2020; 177():1-24. PubMed ID: 32770396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CCR1: a new target for progressive kidney disease.
    Ninichuk V; Anders HJ
    Am J Nephrol; 2005; 25(4):365-72. PubMed ID: 16088077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.